Zihao Dai

1.4k total citations · 1 hit paper
23 papers, 857 citations indexed

About

Zihao Dai is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zihao Dai has authored 23 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zihao Dai's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), RNA modifications and cancer (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Zihao Dai is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), RNA modifications and cancer (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Zihao Dai collaborates with scholars based in China, United States and Hong Kong. Zihao Dai's co-authors include Sui Peng, Junbin Liao, Shuibin Lin, Ming Kuang, Lixia Xu, Hai‐Ning Liu, Wanjie Zhu, Ming Kuang, Baogang Peng and Shenghua Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cell and Cancer Research.

In The Last Decade

Zihao Dai

21 papers receiving 855 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression

2021 201 citations Zihao Dai, Hai‐Ning Liu et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zihao Dai China	12	595	354	164	113	94	23	857
Kai Lei China	7	274 0.5×	155 0.4×	128 0.8×	81 0.7×	58 0.6×	21	493
Zhouhong Ge China	10	565 0.9×	500 1.4×	287 1.8×	85 0.8×	46 0.5×	12	933
Siyun Shen China	9	306 0.5×	203 0.6×	214 1.3×	70 0.6×	56 0.6×	13	546
Imane El Dika United States	13	207 0.3×	145 0.4×	214 1.3×	178 1.6×	109 1.2×	30	573
Pai‐Chi Teng United States	7	239 0.4×	215 0.6×	173 1.1×	143 1.3×	89 0.9×	15	506
Lun Qin China	6	267 0.4×	242 0.7×	117 0.7×	127 1.1×	59 0.6×	7	532
Jun-sheng Ni China	15	335 0.6×	206 0.6×	74 0.5×	54 0.5×	52 0.6×	28	484
Junhao Zheng China	9	292 0.5×	223 0.6×	61 0.4×	118 1.0×	62 0.7×	30	492
Ningning Dong China	11	194 0.3×	142 0.4×	178 1.1×	44 0.4×	93 1.0×	20	479
Sheng Zhao China	15	183 0.3×	111 0.3×	159 1.0×	58 0.5×	123 1.3×	48	601

Countries citing papers authored by Zihao Dai

Since Specialization

Citations

This map shows the geographic impact of Zihao Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihao Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihao Dai more than expected).

Fields of papers citing papers by Zihao Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihao Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihao Dai. The network helps show where Zihao Dai may publish in the future.

Co-authorship network of co-authors of Zihao Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Zihao Dai. A scholar is included among the top collaborators of Zihao Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihao Dai. Zihao Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Zihao, Yifan Li, Pengfei Fang, et al.. (2025). A Potent Oral Sialylation Inhibitor Augments the Immunotherapy in Pancreatic Ductal Adenocarcinoma. ACS Central Science. 11(10). 1969–1983.

Jiang, Jian, Tong Shen, Dan Chen, et al.. (2025). FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Cell Biochemistry and Biophysics. 83(2). 2441–2452. 2 indexed citations

Zhang, Di, Tong Shen, Feng Gao, et al.. (2025). Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage. Therapeutic Advances in Gastroenterology. 18. 1128511571–1128511571.

Zhang, Qingwei, Xiaolu Lin, Zihao Dai, et al.. (2024). Hypoxia and low-glucose environments co-induced HGDILnc1 promote glycolysis and angiogenesis. Cell Death Discovery. 10(1). 132–132. 3 indexed citations

Zhang, Di, et al.. (2024). One-Stage Intraoperative ERCP combined with Laparoscopic Cholecystectomy Versus Two-Stage Preoperative ERCP Followed by Laparoscopic Cholecystectomy in the Management of Gallbladder with Common Bile Duct Stones: A Meta-analysis. Advances in Therapy. 41(10). 3792–3806. 3 indexed citations

Zhang, Qingwei, Zhengjie Zhang, Zihao Dai, et al.. (2024). Multi-step validation of a deep learning-based system with visual explanations for optical diagnosis of polyps with advanced features. iScience. 27(4). 109461–109461. 2 indexed citations

Dai, Zihao, Wanjie Zhu, Xinyue Zhang, et al.. (2023). METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Molecular Therapy. 31(11). 3225–3242. 30 indexed citations

Liu, Hai‐Ning, Xuezhen Zeng, Xuxin Ren, et al.. (2022). Targeting tumour-intrinsic N ⁷ -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy. Gut. 72(8). 1555–1567. 53 indexed citations

Huang, Manling, Jianting Long, Yi Zhao, et al.. (2022). METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer Research. 83(1). 89–102. 138 indexed citations

10.

Wei, Mengchao, Manxia Lin, Xian Zhong, et al.. (2022). Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma. Annals of Surgical Oncology. 29(8). 5144–5153. 2 indexed citations

11.

Zhang, Qingwei, Zihao Dai, Xiaoyi Wang, et al.. (2022). Influence of early colorectal cancer component on the positive margins after endoscopic resection: a retrospective study. BMC Cancer. 22(1). 120–120. 2 indexed citations

12.

Chen, Zhihang, Wanjie Zhu, Shenghua Zhu, et al.. (2021). METTL1 promotes hepatocarcinogenesis via m⁷G tRNA modification‐dependent translation control. SHILAP Revista de lepidopterología. 11(12). e661–e661. 134 indexed citations

13.

Rong, Rong, Wei Chen, Zihao Dai, et al.. (2021). Improvement of the management of mental well-being and empathy in Chinese medical students: a randomized controlled study. BMC Medical Education. 21(1). 378–378. 14 indexed citations

14.

Dai, Zihao, Zongren Wang, Kai Lei, et al.. (2021). Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth. Cancer Letters. 503. 1–10. 62 indexed citations

15.

Dai, Zihao, Hai‐Ning Liu, Junbin Liao, et al.. (2021). N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Molecular Cell. 81(16). 3339–3355.e8. 201 indexed citations breakdown →

16.

Dai, Zihao, Qiwen Wang, Qingwei Zhang, et al.. (2020). Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study. EBioMedicine. 60. 102979–102979. 4 indexed citations

17.

He, Minghui, Zihao Dai, Jun Yu, et al.. (2019). Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Annals of Oncology. 30(6). 990–997. 90 indexed citations

18.

Chen, Shuling, Huilin Jin, Zihao Dai, et al.. (2019). Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma. Cancer Medicine. 8(4). 1530–1539. 13 indexed citations

19.

Su, Tianhong, Junbin Liao, Zihao Dai, et al.. (2018). Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Oncogene. 37(26). 3514–3527. 60 indexed citations

20.

Chen, Shuling, Zhenwei Peng, Mengchao Wei, et al.. (2018). Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis. BMC Cancer. 18(1). 392–392. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact